▮ Slide Shows

▮ Entertainment

Top Stories
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ Premium NEW

▮ More

Wall Street Events

NortonLifeLock Q1 23 Earnings Conference Call At 5:00 PM ET

By RTTNews Staff Writer ✉ | Published: 8/4/2022 3:00 PM ET

NortonLifeLock Inc. (NLOK) will host a conference call at 5:00 PM ET on Aug. 4, 2022, to discuss Q1 23 earnings results.

To access the live webcast, log on to https://investor.nortonlifelock.com/events-and-presentations/default.aspx

For comments and feedback contact: editorial@rttnews.com

Biotech Stocks Facing FDA Decision In June 2022

Biotech Stocks Facing FDA Decision In June 2022

Biotech Stocks Facing FDA Decision In March 2022

Biotech Stocks Facing FDA Decision In March 2022

Biotech Stocks Facing FDA Decision In February 2022 non small cell lung cancer chemotherapy

Biotech Stocks Facing FDA Decision In February 2022

Latest Updates on COVID-19

CDC No Longer Recommends Quarantine, Screening For COVID-19

U.S. Reports 128K New Covid Cases, 464 Deaths

U.S. Reports 10,263 New Covid Cases, 11 Deaths

U.S. Reports 167K New Covid Cases, 625 Deaths

Biden To Return To Public Life After Testing Covid Negative

Read More

COVID-19: Drugs in Development

RELATED NEWS

NortonLifeLock Inc. Q1 Profit Increases, beats estimates

NortonLifeLock Q1 23 Earnings Conference Call At 5:00 PM ET

Follow RTT

Editor's Pick
Most Read
Most Emailed

CDC No Longer Recommends Quarantine, Screening For COVID-19

Johnson & Johnson To Discontinue Talc-based Baby Powder

Disney+ With No Ads To Now Come At $3 Premium Per Month

U.S. To Get Base Powder For 6 Mln Bottles Of Specialty Formula From Mexico

Deutsche Telekom Lifts FY22 View Despite Weak Q2 Profit; Stock Up

Lyons Magnus Expands Recall Of Nutritional And Beverage Products

Elon Musk Sells Tesla Stock Worth $6.9 Bln To Avoid Emergency Sale

WhatsApp Introducing New Privacy Features

Prudential Plc Turns To Net Profit In H1; Pre-tax Profit Down

FDA Authorizes Emergency Use Of JYNNEOS Vaccine For Monkeypox

Lyft Launches Media And Advertising Business

Sysco Q4 Profit Surges, Looks Ahead To Adj. Earnings Growth In FY23

Sysco Q4 Profit Surges, Looks Ahead To Adj. Earnings Growth In FY23

Lyons Magnus Expands Recall Of Nutritional And Beverage Products

Elon Musk Sells Tesla Stock Worth $6.9 Bln To Avoid Emergency Sale

BioNTech Q2 Profit Down; Backs FY22 COVID-19 Vaccine Revenue View - Quick Facts

FDA Authorizes Emergency Use Of JYNNEOS Vaccine For Monkeypox

Chicken Soup For The Soul Entertainment Rallies After Redbox Shareholders Approve Acquisition

Novavax Lowers FY22 Revenue Outlook

888 Holdings H1 Earnings Fall

Deutsche Telekom Lifts FY22 View Despite Weak Q2 Profit; Stock Up

Kodiak Sciences Reports Positive Topline Results From Phase 3 Study Of Tarcocimab Tedromer

Lyft Launches Media And Advertising Business

Baidu To Offer China's First-ever Commercial Fully Driverless Robotaxi Services

UPS To Acquire Bomi Group To Enhance Healthcare Logistics

Aegon Q2 Operating Result Declines

Energizer Holdings Q3 Profit Climbs, Tops Estimates; Now Sees FY22 Adj. EPS At Low End Of View

Pfizer To Buy Global Blood Therapeutics In $5.4 Bln All-cash Deal

Novavax Lowers FY22 Revenue Outlook

Professional Holding Rallies On News Of Acquisition By Seacoast Banking

Pfizer: Phase 3 Study Of 20-Valent Pneumococcal Conjugate Vaccine Posts Positive Results In Infants

Prudential Plc Turns To Net Profit In H1; Pre-tax Profit Down

Cerevel Prices Public Offering Of Common Stock, And Concurrent Private Offering Of Senior Notes

Pfizer, Valneva Initiate Phase 3 Study Of Lyme Disease Vaccine Candidate VLA15

Innovent : Phase 2 Study Of Picankibart In Chinese Patients With Psoriasis Meets Primary Goal

Perrigo Company plc Q2 Earnings Summary